Package 21130-546-63

{"route": ["ORAL"], "spl_id": "b75fd606-49ad-47c4-8f4c-b4dd4eb9ce9d", "openfda": {"nui": ["N0000000151", "N0000175784"], "unii": ["H0G9379FGK", "5QZO15J2Z8", "NBZ3QY004S"], "rxcui": ["283641"], "spl_set_id": ["885f43ab-5c14-417b-aab7-e887dfc48f2e"], "pharm_class_epc": ["Histamine-2 Receptor Antagonist [EPC]"], "pharm_class_moa": ["Histamine H2 Receptor Antagonists [MoA]"], "manufacturer_name": ["Safeway"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "25 TABLET, CHEWABLE in 1 BOTTLE (21130-546-63)", "package_ndc": "21130-546-63", "marketing_start_date": "20211101"}, {"sample": false, "description": "50 TABLET, CHEWABLE in 1 BOTTLE (21130-546-71)", "package_ndc": "21130-546-71", "marketing_start_date": "20211101"}], "brand_name": "signature care acid reducer complete", "product_id": "21130-546_b75fd606-49ad-47c4-8f4c-b4dd4eb9ce9d", "dosage_form": "TABLET, CHEWABLE", "pharm_class": ["Calculi Dissolution Agent [EPC]", "Histamine H2 Receptor Antagonists [MoA]", "Histamine-2 Receptor Antagonist [EPC]", "Increased Large Intestinal Motility [PE]", "Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]", "Inhibition Small Intestine Fluid/Electrolyte Absorption [PE]", "Magnesium Ion Exchange Activity [MoA]", "Osmotic Activity [MoA]", "Osmotic Laxative [EPC]", "Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]"], "product_ndc": "21130-546", "generic_name": "Famotidine, Calcium Carbonate, Magnesium Hydroxide", "labeler_name": "Safeway", "product_type": "HUMAN OTC DRUG", "brand_name_base": "signature care acid reducer complete", "active_ingredients": [{"name": "CALCIUM CARBONATE", "strength": "800 mg/1"}, {"name": "FAMOTIDINE", "strength": "10 mg/1"}, {"name": "MAGNESIUM HYDROXIDE", "strength": "165 mg/1"}], "application_number": "ANDA077355", "marketing_category": "ANDA", "marketing_start_date": "20211101", "listing_expiration_date": "20261231"}